Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Volumn 6, Issue 1, 2000, Pages 20-25

  Hershon, K S ^a   Hershon, P M ^a  

^a N Shore Diabet and Endocr Assoc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CHROMAN DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; THIAZOLE DERIVATIVE; TROGLITAZONE;

AGED; ARTICLE; BLOOD; COHORT ANALYSIS; DIET THERAPY; DOSE RESPONSE; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT;

AGED; CHROMANS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; OUTPATIENTS; SULFONYLUREA COMPOUNDS; THIAZOLES; THIAZOLIDINEDIONES;

MLCS; MLOWN;

EID: 0033766929     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.6.1.20     Document Type: Article

References (0)